catalyst · primary record
EOHILIA
Patent expiry · 2026-11-09 · BUDESONIDE
| Company | TAKEDA PHARMACEUTICALS USA INC |
|---|---|
| Ticker | Not stated |
| Impact | high |
| Detail | US 8679545 expires · BUDESONIDE |
| Source | FDA Orange Book |
Provenance
- Source: FDA Orange Book
- Fetched at: 2026-11-02T01:50:29.668Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: TAKEDA PHARMACEUTICALS USA INC:EOHILIA:2026-11-09:US 8679545 expires · BUDESONIDE
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.